Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Herceptin and Paclitaxel in Locally Advanced Breast Cancer With Her-2 Overexpression

NCT00009997 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00009997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00009997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Herceptin and Paclitaxel in Locally Advanced Breast Cancer With Her-2 Overexpression
Lead sponsor
NYU Langone Health
Phase
Phase 1
Overall status
Completed
Start date
March 31, 1999
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer